David MacDonald

David MacDonald

Chief Tech/Sci/R&D Officer at XORTX THERAPEUTICS INC.
Health Technology
Consumer Services
Miscellaneous

Profile

David MacDonald currently works at XORTX Therapeutics, Inc., as Chief Technology Officer from 2022.
Dr. MacDonald also formerly worked at Active Pass Pharmaceuticals, Inc., as President & Chief Executive Officer, MSI Methylation Sciences, Inc., as Chief Technology Officer & Vice President from 2008 to 2017, Hemosol Corp., as Section Leader, Syntex, Inc., as Staff Researcher, Biovail Contract Research Division, as General Manager, and Immunoflex Therapeutics, Inc., as Chief Technology Officer from 2020 to 2021.
Dr. MacDonald received his doctorate degree from the University of Alberta.

David MacDonald active positions

CompaniesPositionStart
XORTX THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 2022-01-19

Former positions of David MacDonald

CompaniesPositionEnd
Immunoflex Therapeutics, Inc.
Chief Tech/Sci/R&D Officer 2020-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
President -
See the detail of David MacDonald's experience

Training of David MacDonald

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Health Technology

Miscellaneous

Commercial Services

Health Technology

Immunoflex Therapeutics, Inc.

  1. Stock Market
  2. Insiders
  3. David MacDonald
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!